Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons dr. B. Koopman

Publicaties

Clonal Progression and Leukemic Transformation of a TP53 Mutated Post-Polycythaemia Vera Myelofibrosis

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy

95P Automatic data processing to identify EGFR mutations in pathology reports of patients with non-small cell lung cancer (NSCLC)

Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature

Clinical decision-making strategies for rare somatic variants in cancer

Detection of NTRK Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort

Molecular markers - PI3K / PIK3CA

Proof of concepts for automated extraction of mutation status from narrative pathology reports: KRAS G12C mutations and NTRK fusions in non-squamous non-small cell lung cancer

A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses

Pers/media

Breed testen en anticiperen op nieuwe behandelmogelijkheden

Moleculaire Tumor Boards

Interview by ZonMw

Interview for magazine "Longkanker"